0001819934-22-000001.txt : 20220119 0001819934-22-000001.hdr.sgml : 20220119 20220119165403 ACCESSION NUMBER: 0001819934-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220119 DATE AS OF CHANGE: 20220119 EFFECTIVENESS DATE: 20220119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AmbAgon Therapeutics Inc. CENTRAL INDEX KEY: 0001819934 IRS NUMBER: 850560627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-429995 FILM NUMBER: 22539432 BUSINESS ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (415) 235-6373 MAIL ADDRESS: STREET 1: 953 INDIANA STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 D 1 primary_doc.xml X0708 D LIVE 0001819934 AmbAgon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 (415) 235-6373 DELAWARE None None Corporation true 2020 Scott Clarke c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Director Michelle Arkin c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Janwillem Naesens c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Margarita Chavez c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Peter Dudek c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Roel Bulthuis c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Adam Rosenberg c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Melissa McCracken c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Director Nancy Pryer c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Bryan Miller c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Christian Ottmann c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Josh Seidenfeld c/o Ambagon Therapeutics Inc. 953 Indiana Street San Francisco CA CALIFORNIA 94107 Executive Officer Biotechnology Decline to Disclose 06b false 2022-01-05 false true false 0 84999994 44999996 39999998 Series A Preferred Stock and the Common Stock issuable upon the conversion thereof. false 9 0 0 0 false AmbAgon Therapeutics Inc. /s/Scott Clarke Scott Clarke Chief Executive Officer 2022-01-19